Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Novel high-throughput screening system for identifying STAT3-SH2 antagonists.

Yutaka Uehara1, Masato Mochizuki, Kenji Matsuno

  • 1Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.

Biochemical and Biophysical Research Communications
|March 17, 2009
PubMed
Summary

Researchers identified 5,15-diphenylporphyrin (5,15-DPP) as a selective STAT3-SH2 antagonist. This compound inhibits STAT3 dimerization and downstream effects, offering a potential cancer therapy approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

The American journal of gastroenterology·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature.

Journal of clinical medicine·2026
Same author

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Elucidating chiral myosin-induced actin dynamics: From single-filament behavior to collective structures.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan.

Journal of gastroenterology·2026
Same author

Primary Hepatic Squamous Cell Carcinoma.

Diagnostics (Basel, Switzerland)·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Constitutive activation of Signal Transducer and Activator of Transcription 3 (STAT3) is common in human cancers.
  • STAT3 activation relies on dimerization through a pTyr-SH2 interaction, making it a therapeutic target.
  • Inhibiting this interaction is a promising strategy for cancer treatment.

Purpose of the Study:

  • To develop a high-throughput screening (HTS) system to identify selective STAT3 inhibitors.
  • To find novel compounds that antagonize the STAT3 pTyr-SH2 interaction.

Main Methods:

  • Developed a biochemical HTS assay utilizing AlphaScreen technology.
  • Screened chemical libraries to identify STAT3-SH2 antagonists.
  • Assessed the effects of identified compounds on STAT3 activity in cellular models.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Related Experiment Videos

Last Updated: Jun 24, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Main Results:

  • Identified 5,15-diphenylporphyrin (5,15-DPP) as a selective STAT3-SH2 antagonist.
  • Demonstrated that 5,15-DPP selectively inhibits STAT3 nuclear translocation and DNA binding.
  • Observed suppression of IL-6-dependent STAT3 dimerization, c-myc promoter binding, and c-myc protein expression by 5,15-DPP.

Conclusions:

  • The developed HTS system is effective for identifying STAT3-SH2 antagonists.
  • 5,15-DPP is a potent inhibitor of STAT3 signaling pathways crucial for cancer cell proliferation.
  • This study provides a novel therapeutic lead for targeting STAT3-driven malignancies.